GEIST:UPC Searchengine

UPC_CFI_123/2024

Alexion Pharmaceuticals, Inc. v. Samsung Bioepis NL B.V.

Datum
2024-06-26
Kammer
Hamburg (DE) Local Division
Verfahrensart
Application for provisional measures
Sprache
EN

Metadaten

Fall-IDUPC_CFI_123-2024-f09ab377593f
Aktenzeichen
RegisterzeichenUPC_CFI_123/2024
EntscheidungsreferenzORD_38059/2024
Schlagwörter
Leitsätze

Dokumente und Volltext

Textextraktion: pypdf | Seiten: 24

Hamburg - Local Division UPC_CFI_124/2024 Final Order of the Court of First Instance of the Unified Patent Court delivered on 26/06/2024 HEADNOTES: 1. The patent claim is always to be interpreted from the point of view of a person skilled in th e art. Additionally, the skilled person is taking the purpose of every patent claim into account, to provide the average person skilled in the art with a technical teaching which, when reworked, leads to the intended success of the invention. 2. The court must be convinced of the validity of a patent in suit with a sufficient degree of certainty. A decision on provisional measures cannot be based solely on the court's view of the validity of the patent in suit , but also on the likelihood that the oppositio n division of the EPO will revoke the pate ...